Vikramm Narayan News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Vikramm Narayan. Real-time updates on events, politics, business and more.

Narayan Discusses Bladder Preservation and the Role of Gene Therapies in NMIBC

May 23, 2024

Vikram M. Narayan, MD, highlights takeaways from 5-year follow-up data examining the gene therapy nadofaragene firadenovec and details promising emerging therapies for bladder cancer.

Emory University Hospital United States Emory University Grady Memorial Hospital Vikramm Narayan Winship Cancer Institute In Atlanta

Source: onclive.com

Adstiladrin Leads to Beneficial Outcomes in Some Bladder Cancers

January 29, 2024

Urinary minimal residual disease-negative status was related to preventing the return of cancer when certain patients with bladder cancer received Adstiladrin.

United States Vikramm Narayan Emory University School Of Medicine Ferring Pharmaceuticals Emory University School Bladder Cancer

Source: curetoday.com

Urinary MRD Status Potentially Predictive of Recurrence in BCG-Unresponsive NMIBC

January 27, 2024

Assessment of urinary MRD status identified and enabled quantification of molecular responses with nadofaragene firadenovec in BCG-unresponsive NMIBC.

United States Vikramm Narayan Intravesical Administration Ferring Pharmaceuticals Urology At Emory University School Of Medicine Emory University School

Source: onclive.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Vikramm Narayan News Today

Narayan Discusses Bladder Preservation and the Role of Gene Therapies in NMIBC

Adstiladrin Leads to Beneficial Outcomes in Some Bladder Cancers

Urinary MRD Status Potentially Predictive of Recurrence in BCG-Unresponsive NMIBC

Explore More Categories